Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT04714138
  4. Details
NCT04714138 Clinical Trial

Remote Video Consultation for Quality of Life Assessment in Patients Hospitalised After COVID-19 Infection

Covid19 Clinical Trial

— TELECOVID  

Official title:
Remote Evaluation of Quality of Life and Functional Capacities in Patients Hospitalised for COVID-19: a Prospective Observational Study

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04714138
Other study ID # 2020-A03110-39
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 5, 2021
Est. completion date June 15, 2021

Study information
Verified date August 2021
Source Groupe Hospitalier du Havre
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Around 90.000 patients have been hospitalised due to COVID-19 infection in France between March 1st and June 15th; 19% of those requiring intensive care. Approximately 80% of these patients have been discharged home by September 30th. Nonetheless, COVID-19 infection along with intensive care consequences are very likely to impede those patients quality of life and functional capacities. This study aims to describe the quality of life outcomes and functional capacities of COVID-19 survivors, at least 6 months after primary care hospital discharge.

Recruitment information / eligibility
Status Completed
Enrollment 157
Est. completion date June 15, 2021
Est. primary completion date March 20, 2021
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patient - COVID-19 hospitalisation at Le Havre hospital between March 1st and May 11th - Non-opposition during first phone contact Exclusion Criteria: - Guardianship - Juvenile patients - Pregnancy - Inability to communicate - Cognitive disorders - Deceased patient

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
France Groupe Hospitalier Du Havre Montivilliers Normandie

Sponsors (1)
Lead Sponsor Collaborator
Groupe Hospitalier du Havre

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Health-related quality of life Measured with the Short-Form health survey (SF-36) scale (score ranging form 0 (worst score) to 100 (best score) per item) 10 to 12 months after hospital discharge during remote video consultation
Secondary Functional capacity One-minute Sit-to-stand test 10 to 12 months after hospital discharge during remote video consultation
Secondary Independency KATZ score (ranging 0 (fully dependent) to 6 (fully independent)) 10 to 12 months after hospital discharge during remote video consultation
See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Active, not recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3